Meropenem | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Meropenem
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Meropenem

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

55 API Suppliers, 26 USDMF, 10 CEP/COS, 14 JDMF, 6 EU WC, 16 KDMF, 4 NDC API, 22 Listed Suppliers, $ API Reference Price

55 API Suppliers
26 USDMF
10 CEP/COS
14 JDMF
6 EU WC
16 KDMF
4 NDC API
22 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

173 FDF Dossiers, 30 FDA Orange Book, 48 Europe, 13 Canada, 24 South Africa, 58 Listed Dossiers

173 FDF Dossiers
30 FDA Orange Book
48 Europe
13 Canada
24 South Africa
58 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - 1GM/VIAL;1GM/VIAL, INJECTABLE;INJECTION - 1GM/VIAL, INJECTABLE;INJECTION - 500MG/VIAL

POWDER;INTRAVENOUS - 1GM/VIAL;1GM/VIAL
INJECTABLE;INJECTION - 1GM/VIAL
INJECTABLE;INJECTION - 500MG/VIAL

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 33 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
33 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 30 Finished Drug Prices, 10 Annual Reports

1 US Medicaid Prescriptions
30 Finished Drug Prices
10 Annual Reports

MARKET PLACE

47 APIs, 22 FDF Dossiers, 2 Intermediates

47 APIs
22 FDF Dossiers
2 Intermediates

PATENTS & EXCLUSIVITIES

8 US Patents, 2 US Exclusivities, 4 Health Canada Patents

8 US Patents
2 US Exclusivities
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 4 Others

1 EDQM
1 USP
4 Others

$ API Ref.Price (USD/KG) : 927 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8REMPEX

filter Patent Number Reset all filters

8 All

01 18680136

02 19694025

03 110172874

04 110183034

05 110561675

06 111007206

07 111376237

08 112171772

filter API Patent Reset all filters

8 All

01 2Y

02 6Blank

filter FDF Patent Reset all filters

8 All

01 2Y

02 6Blank

filter Expiration Date Reset all filters

8 All

01 62031-08-08

02 12031-08-29

03 12039-04-06

Product Main Page

01

REMPEX

MEROPENEM; VABORBACTAM

PharmScience R&D

Not Confirmed

REMPEX

U.S.A

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 9694025

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-2120

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

REMPEX

MEROPENEM; VABORBACTAM

PharmScience R&D

Not Confirmed

REMPEX

U.S.A

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 10561675

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-2490

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

03

REMPEX

MEROPENEM; VABORBACTAM

PharmScience R&D

Not Confirmed

REMPEX

U.S.A

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-04-06

MEROPENEM; VABORBACTAM

US Patent Number : 11376237

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-3421

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-04-06

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

04

REMPEX

MEROPENEM; VABORBACTAM

PharmScience R&D

Not Confirmed

REMPEX

U.S.A

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 10183034

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-2490

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

05

REMPEX

MEROPENEM; VABORBACTAM

PharmScience R&D

Not Confirmed

REMPEX

U.S.A

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 11007206

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-3128

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

06

REMPEX

MEROPENEM; VABORBACTAM

PharmScience R&D

Not Confirmed

REMPEX

U.S.A

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 12171772

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 209776

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

07

REMPEX

MEROPENEM; VABORBACTAM

PharmScience R&D

Not Confirmed

REMPEX

U.S.A

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-29

MEROPENEM; VABORBACTAM

US Patent Number : 8680136

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209776

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-29

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

08

REMPEX

MEROPENEM; VABORBACTAM

PharmScience R&D

Not Confirmed

REMPEX

U.S.A

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 10172874

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209776

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!